![](https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/tvm-capital-healthcare-invests-35m-in-saudi-generics-and-biosimilars/17536654-1-eng-GB/TVM-Capital-Healthcare-invests-35m-in-Saudi-generics-and-biosimilars.jpg)
TVM Capital Healthcare invests $35m in Saudi generics and biosimilars from BioPharma-Reporter.com
The Dubai and Singapore-based investor’s cash is aimed to accelerate the plans of Boston Oncology Arabia to move into full formulation and fill and finish manufacturing at its local facilities. TVM will also help the manufacturer to tap into the former’s …